Lipo-B with B-12

Lipo-B Research in Lab Rats

This product is not intended for weight loss, human consumption, or veterinary use. It is sold for research purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.

L-Carnitine 200mg
Arginine 20mg
Methionine 25mg
Inositol 50mg
Choline 50mg
B5 25mg
B6 25mg
B12 1mg

Lipo-B is often used in clinical and wellness settings for weight management, typically contain a blend of lipotropic compounds such as methionine, inositol, choline (MIC), along with vitamin B12. While their use in humans is growing in popularity, animal studies—particularly those involving lab rats—have provided useful insights into the physiological mechanisms and potential therapeutic applications of Lipo-B components.

In preclinical studies, choline and inositol have been shown to play key roles in lipid metabolism and liver function. Choline supplementation in rats demonstrated a protective effect against hepatic steatosis, particularly in high-fat diet models, by enhancing lipid transport and preventing fat accumulation in the liver (Zeisel et al., 2003). Inositol, meanwhile, has shown insulin-sensitizing effects and helped improve lipid profiles in rodent models with metabolic syndrome (Croze & Soulage, 2013).

Methionine, another key lipotropic agent, serves as a methyl donor and plays a role in glutathione production. In rats, methionine supplementation has been linked to improved antioxidant status and protection against oxidative stress-induced liver injury (Li et al., 2009).

Vitamin B12, frequently included in Lipo-B formulations, contributes to energy production and red blood cell synthesis. While not directly lipotropic, its deficiency in rodent models has been associated with impaired energy metabolism and fat accumulation.

Together, these findings suggest that Lipo-B’s components may enhance fat metabolism, reduce liver fat, and improve metabolic function in rats. However, further controlled studies using full Lipo-B formulations are needed to validate these findings and assess synergistic effects.

References

• Zeisel, S. H. (2003). Choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. FASEB J, 17(8), 998-1001. https://pubmed.ncbi.nlm.nih.gov/12724353
• Croze, M. L., & Soulage, C. O. (2013). Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95(10), 1811-1827. https://pubmed.ncbi.nlm.nih.gov/23871734
• Li, T. W. H., et al. (2009). Methionine and choline regulate hepatic lipid metabolism via the SAM–SIRT1–PPARα pathway. J Lipid Res, 50(2), 249-258. https://pubmed.ncbi.nlm.nih.gov/18952569